In the media 8 Jul 2026 No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials The Print
In the media 1 Aug 2026 End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment Daily Nation
In the media 30 Jul 2026 WHO approves new shorter, less painful Kala-azar treatment for East Africa New Vision
Viewpoints 30 Jul 2026 Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases Stat News
In the media 15 Jul 2026 Dengue outbreak complicates Bangladesh measles crisis response The Telegraph
Press releases 13 Jul 2026 DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
Press releases 13 Jul 2026 DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals
Scientific articles 9 Jul 2026 Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring PLOS Neglected Tropical Diseases
In the media 9 Jul 2026 Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy The Indian Express
Press Releases Translations 8 Jul 2026 Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia
Press Releases Translations 8 Jul 2026 Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India
Scientific articles 18 Sep 2024 Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis Clinical and Translational Science
Scientific articles 17 Sep 2024 Challenges and advancements in the development of vaccines and therapies against Chagas disease The Lancet Microbe
Scientific articles 13 Sep 2024 Climate change and Trypanosoma cruzi transmission in North and central America The Lancet Microbe
Scientific articles 5 Sep 2024 Hope amidst neglect: Mycetoma Research Center, University of Khartoum. A holistic management approach to achieve the United Nations’ Sustainable Development Goals PLOS Neglected Tropical Diseases
Scientific articles 30 Aug 2024 The case for a global therapeutics development coalition: Building a therapeutics pipeline for pandemic and endemic diseases PLOS Global Public Health
Scientific articles 21 Aug 2024 Disease-specific differences in pharmacokinetics of paromomycin and miltefosine between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients in Eastern Africa The Journal of Infectious Diseases
Scientific articles 15 Aug 2024 Paving the way for affordable and equitable liposomal amphotericin B access worldwide The Lancet Global Health
Scientific articles 15 Aug 2024 A guide for the generation of repositories of clinical samples for research on Chagas disease PLOS Neglected Tropical Diseases
Scientific articles 15 Aug 2024 A standardized clinical database for research in Chagas disease: The NHEPACHA network PLOS Neglected Tropical Diseases
Scientific articles 8 Aug 2024 The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis Trends in Parasitology
Scientific articles 5 Aug 2024 How do we classify organ involvement in Chagas disease? A systematic review of organ involvement since 1909, highlighting the urgent need for a universal classification system in chronic Chagas disease PLOS Neglected Tropical Diseases
Scientific articles 1 Aug 2024 Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial Lancet Infectious Diseases
Scientific articles 15 Jul 2024 Differences in the cellular immune response during and after treatment of Sudanese patients with post-kala-azar dermal leishmaniasis, and possible implications for outcome Journal of Epidemiology and Global Health
Scientific articles 15 Jul 2024 Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements Wellcome Open Research
Scientific articles 2 Jul 2024 Design, conduct, analysis, and reporting of therapeutic efficacy studies in visceral leishmaniasis: A systematic review of published reports, 2000–2021 American Journal of Tropical Medicine and Hygiene
Scientific articles 20 Jun 2024 A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh PLOS Neglected Tropical Diseases